​

Solventum (SOLV) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

SOLV Stock Forecast

Solventum (SOLV) stock forecast, based on 11 Wall Street analysts, predicts a 12-month average price target of $95.80, with a high of $105.00 and a low of $77.00. This represents a 25.25% increase from the last price of $76.49.

$50 $61 $72 $83 $94 $105 High: $105 Avg: $95.8 Low: $77 Last Closed Price: $76.49

SOLV Stock Rating

Solventum stock's rating consensus is Buy, based on 11 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (63.64%), 3 Hold (27.27%), 1 Sell (9.09%), and 0 Strong Sell (0.00%).

Buy
Total 11 0 1 3 7 Strong Sell Sell Hold Buy Strong Buy

SOLV Price Target Upside V Benchmarks

TypeNameUpside
StockSolventum25.25%
SectorHealthcare Stocks 15.45%
IndustryMedical Care Facilities Stocks21.59%

Price Target Trends

1M3M12M
# Anlaysts348
Avg Price Target$100.67$100.50$92.38
Last Closing Price$76.49$76.49$76.49
Upside/Downside31.61%31.39%20.77%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 262551114
Jan, 262371114
Dec, 252281114
Nov, 252281-13
Oct, 252281-13
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 26, 2026Brett FishbinKeyBanc$97.00$78.9122.92%26.81%
Jan 20, 2026Mizuho Securities$100.00$79.4825.82%30.74%
Jan 07, 2026Stifel Nicolaus$105.00$83.1626.26%37.27%
Dec 02, 2025Ryan ZimmermanBTIG$100.00$85.5616.88%30.74%
Oct 01, 2025Kevin CaliendoUBS$77.00$73.005.48%0.67%
Jul 15, 2025Patrick WoodMorgan Stanley$103.00$73.6839.79%34.66%
Mar 03, 2025Mizuho Securities$82.00$80.162.30%7.20%
Feb 28, 2025Wells Fargo$75.00$79.75-5.96%-1.95%
Dec 03, 2024Steven ValiquetteMizuho Securities$70.00$72.28-3.15%-8.48%
Oct 07, 2024Rick WiseStifel Nicolaus$82.00$66.2923.70%7.20%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 26, 2026KeyBancSector WeightOverweightupgrade
Dec 17, 2025Piper SandlerOverweightOverweighthold
Dec 02, 2025BTIGBuyReduceupgrade
Dec 02, 2025BTIGNeutralBuyupgrade
Nov 21, 2025UBSNeutralNeutralhold
Oct 01, 2025UBSNeutralinitialise
Sep 11, 2025JefferiesHoldinitialise
Aug 08, 2025Piper SandlerOverweightOverweighthold
Jul 15, 2025Morgan StanleyEqual-WeightOverweightupgrade
Jun 06, 2025KeyBancSector Weightinitialise

Financial Forecast

EPS Forecast

$2 $3 $4 $5 $6 $7 $8 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.79$2.77----
Avg Forecast-$6.59$5.50$5.87$6.19$6.30
High Forecast-$6.62$5.76$6.35$6.26$6.37
Low Forecast-$6.57$5.23$5.29$6.13$6.23
Surprise %--57.97%----

Revenue Forecast

$8B $8B $8B $8B $9B $9B Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$8.20B$8.25B----
Avg Forecast$8.20B$8.23B$8.26B$8.41B$8.48B$8.57B
High Forecast$8.27B$8.31B$8.33B$8.41B$8.48B$8.65B
Low Forecast$8.13B$8.22B$8.22B$8.40B$8.48B$8.50B
Surprise %-0.27%----

Net Income Forecast

$450M $630M $810M $990M $1B $1B Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.35B$479.00M----
Avg Forecast-$1.14B$947.53M$1.00B$1.07B$1.09B
High Forecast-$1.14B$993.31M$1.09B$1.08B$1.10B
Low Forecast-$1.13B$901.75M$911.80M$1.06B$1.08B
Surprise %--57.89%----

SOLV Forecast FAQ

Is Solventum stock a buy?

Solventum stock has a consensus rating of Buy, based on 11 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 7 Buy, 3 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Solventum is a favorable investment for most analysts.

What is Solventum's price target?

Solventum's price target, set by 11 Wall Street analysts, averages $95.8 over the next 12 months. The price target range spans from $77 at the low end to $105 at the high end, suggesting a potential 25.25% change from the previous closing price of $76.49.

How does Solventum stock forecast compare to its benchmarks?

Solventum's stock forecast shows a 25.25% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical care facilities stocks industry (21.59%).

What is the breakdown of analyst ratings for Solventum over the past three months?

  • February 2026: 14.29% Strong Buy, 35.71% Buy, 35.71% Hold, 7.14% Sell, 7.14% Strong Sell.
  • January 2026: 14.29% Strong Buy, 21.43% Buy, 50.00% Hold, 7.14% Sell, 7.14% Strong Sell.
  • December 2025: 14.29% Strong Buy, 14.29% Buy, 57.14% Hold, 7.14% Sell, 7.14% Strong Sell.

What is Solventum’s EPS forecast?

Solventum's average annual EPS forecast for its fiscal year ending in December 2025 is $5.5, marking a 98.56% increase from the reported $2.77 in 2024. Estimates for the following years are $5.87 in 2026, $6.19 in 2027, and $6.3 in 2028.

What is Solventum’s revenue forecast?

Solventum's average annual revenue forecast for its fiscal year ending in December 2025 is $8.26B, reflecting a 0.10% increase from the reported $8.25B in 2024. The forecast for 2026 is $8.41B, followed by $8.48B for 2027, and $8.57B for 2028.

What is Solventum’s net income forecast?

Solventum's net income forecast for the fiscal year ending in December 2025 stands at $947.53M, representing an 97.81% increase from the reported $479M in 2024. Projections indicate $1B in 2026, $1.07B in 2027, and $1.09B in 2028.